Fundamental Analysis
33 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -81.1% | -20.3% | 1 / 3 | -9.4% | +2.11 pp | -0.58 pp | +20.9% | 1.99 | 3.91 | 6.148 | −9,4% | 70,0 | −40,0% | 3.91 | 13.17 | −70,3% |
| Pts | 0 | 0 | 4 | 0 | 8 | 4 | 12 | -4 | 12 | |||||||
Valuation annotation:Price: 16.850 (close price on 2026-10-19)EPS (TTM): 4.305
Financial charts
1.Revenue & growth
VND bn6.148Q2/26
1.Revenue & growth
VND bn6.148Q2/26
2.Profit & growth
VND bn14,1Q2/26
3.Profit mix (Penman)
VND bn585Q2/26
4.Margins & cost structure
%7.3%Q2/26
5.Returns & cash cycle
% · days0.1%Q2/26
6.Earnings quality & cash
VND bn-322Q2/26
7.Asset structure
VND bn12.169Q2/26
8.Funding & debt health
VND bn · times12.169Q2/26
9.Revenue backlog
VND bn539Q2/26
10.Valuation
times · %3,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %151Q2/26
Adjusted EPS growth, latest quarter
-81.1%
Average adjusted EPS growth, 3 quarters
-20.3%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
-0.0%
Source: vnstockData through Q2/26